The synthetic biology firm reported a narrower Q2 GAAP loss but missed revenue forecasts by $23.49M.
Ginkgo Bioworks Holdings reported a Q2 GAAP loss of $1.28 per share, beating expectations by $0.06. Revenue reached $19.47M, falling short of estimates by $23.49M.
Analysts had anticipated a wider loss and significantly higher revenue for the quarter. The company’s revenue decline contrasts with prior periods, where performance aligned more closely with projections.
No immediate market reaction was detailed in the release.